Blood-Based Biomarkers and the Future of Alzheimer’s Disease Diagnostics
BY Editorial Team |February 5 2025
4 min read
We sat down with our own Alzheimer’s disease and dementia subject matter expert, Dr. Arindam Ghosh, to learn the potential of blood-based biomarkers to transform the approach to Alzheimer’s disease diagnosis and management.
Exploring the Potential Role of Blood-Based Biomarkers in Identifying and Monitoring Alzheimer's Disease
BY Kinal Bhatt, MD, MPH |December 10 2024
5 min read
At the 2024 Clinical Trials in Alzheimer’s Disease (CTAD 2024) conference in Madrid, Spain, discussed the promise of blood-based diagnostic biomarkers.
Beckman Coulter is thrilled to introduce a revolutionary new web search experience, empowering you to find information faster, making your searches more productive than ever before.
Bacterial Resistance: Actions from the Core Microbiology Lab
BY Deise Y. Rojas |September 23 2024
3 min read
Learn from our MicroTeam some “MicroTips” about the critical role of the microbiology laboratory for patients, reporting, and the larger impact to antimicrobial stewardship.
Alzheimer’s disease: Challenges to diagnosis and the emerging treatment landscape
BY Arindam Ghosh, MBBS, PhD |September 19 2024
5 min read
Alzheimer's disease is the most common form of dementia. The prevalence of this debilitating disease is expected to continue to rise in the coming years as the global population ages, making it an increasingly important global public health issue.
English
